SUBSTITUTED PIPERAZINES AND PIPERIDINES AS MODULATORS OF THE NEUROPEPTIDE Y2 RECEPTOR
申请人:Bonaventure Pascal
公开号:US20070100141A1
公开(公告)日:2007-05-03
The invention provides novel non-peptidic NPY Y2 receptor inhibitors useful in treating or preventing: anxiolytic disorders or depression; injured mammalian nerve tissue; conditions responsive to treatment through administration of a neurotrophic factor; neurological disorders; bone loss; substance related disorders; sleep/wake disorders; cardiovascular disease; obesity; or an obesity-related disorder. Compounds of the invention are also useful in modulating endocrine functions, particularly endocrine functions controlled by the pituitary and hypothalamic glands, and are therefore useful in the treatment or prevention of inovulation and infertility.
[EN] SUBSTITUTED PIPERAZINES AND PIPERIDINES AS MODULATORS OF THE NEUROPEPTIDE Y2 RECEPTOR<br/>[FR] PIPERAZINES ET PIPERIDINES SUBSTITUEES EN TANT QUE MODULATEURS DU RECEPTEUR DU NEUROPEPTIDE Y2
申请人:JANSSEN PHARMACEUTICA NV
公开号:WO2007053436A1
公开(公告)日:2007-05-10
[EN] The invention provides novel non-peptidic NPY Y2 receptor inhibitors (1) useful in treating or preventing: anxiolytic disorders or depression; injured mammalian nerve tissue; conditions responsive to treatment through administration of a neurotrophic factor; neurological disorders; bone loss- substance related disorders; sleep/wake disorders; cardiovascular disease- obesity; or an obesity-related disorder. Compounds of the invention are also useful in modulating endocrine functions, particularly endocrine functions controlled by the pituitary and hypothalamic glands, and are therefore useful in the treatment or prevention of inovulation and infertility. [FR] La présente invention concerne de nouveaux inhibiteurs du récepteur non peptidique NPY Y2 (1) utiles dans le traitement ou la prévention des troubles anxiolytiques ou de la dépression ; une lésion d'un tissu nerveux de mammifère ; des états pathologiques répondant à un traitement par administration d'un facteur neurotrophique ; de troubles neurologiques ; de troubles liés à la perte de substance osseuse ; de troubles du sommeil / éveil ; d'une maladie cardiovasculaire, l'obésité ; ou d'un trouble lié à l'obésité. Des composés de l'invention sont également utiles dans la modulation de fonctions endocriniennes, notamment de fonctions endocriniennes contrôlées par les glandes pituitaires et hypothalamiques, et sont de ce fait utiles dans le traitement ou la prévention de l'anovulation et de stérilité.
The discovery of potent selective NPY Y2 antagonists
作者:Wenying Chai、Victoria D. Wong、Diane Nepomuceno、Pascal Bonaventure、Timothy W. Lovenberg、Nicholas I. Carruthers
DOI:10.1016/j.bmcl.2013.05.038
日期:2013.7
synthesized and tested for binding affinity (IC50) at human Neuropeptide Y Y2 receptor. Various amide related analogs (ureas, reversed amides, and sulfonamides) were evaluated. Several potent and selectiveNPY Y2 antagonists were identified.
合成了一系列具有哌啶基核心的小分子,并测试了对人Neuropeptide YY 2受体的结合亲和力(IC 50)。评估了各种酰胺相关的类似物(脲,反向酰胺和磺酰胺)。鉴定了几种有效的和选择性的NPY Y 2拮抗剂。